Search

Search Constraints

You searched for: Author/Creator Gobom, Johan

Search Results

33. First amyloid β1‐42 certified reference material for re‐calibrating commercial immunoassays. Issue 11 (4th August 2020)

34. Fluid‐based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases. Issue 4 (12th November 2018)

35. GMNC risk alleles in individuals with Alzheimer's disease are associated with cerebrospinal fluid concentrations of proteins involved in neuronal plasticity and blood brain barrier function. (20th December 2022)

36. Immune protein levels in cerebrospinal fluid: Associations with memory scores across the AD spectrum. (1st February 2022)

37. Immune protein levels in cerebrospinal fluid: Associations with memory scores across the AD spectrum. (December 2021)

38. Mass spectrometric measurement of six site‐specific tau phosphorylations in CSF and blood of Alzheimer's disease patients. (31st December 2021)

39. Mass Spectrometry–Based Candidate Reference Measurement Procedure for Quantification of Amyloid-β in Cerebrospinal Fluid. (1st July 2014)

40. Multi‐modal Analysis and Modeling of Human Neurodegenerative Disease to Reveal Disease Mechanisms and Biomarkers. (20th December 2022)